Scott Bornheimer

Company: BD Technologies

Job title: Associate Director - Biomarkers & CDx, Medical & Scientific Affairs

Seminars:

Exploring Innovations in Flow Cytometry as a MRD and CDx Modality 3:10 pm

Join our talk and panel discussion to delve into the latest updates and developments in the use of flow cytometry as a MRD and companion diagnostic (CDx) modality.   This session will provide insights into the decision-making process, highlighting when flow cytometry is the optimal choice for biopharma companies in their drug development journey.   Discover how…Read more

day: Day Two Track C